ESTROGEN RECEPTOR ANALYSIS IN PRIMARY BREAST TUMORS BY LIGAND-BINDING ASSAY, IMMUNOCYTOCHEMICAL ASSAY, AND NORTHERN BLOT: A COMPARISON.ESTROGENIC EFFECT OF A SERIES OF BISPHENOL ANALOGUES ON GENE AND PROTEIN EXPRESSION IN MCF-7 BREAST CANCER CELLS.
Main menu


Marc Lacroix - List of publications - Click here

A LOW-DENSITY DNA MICROARRAY FOR ANALYSIS OF MARKERS IN BREAST CANCER (Review article).


Marc Lacroix, Nathalie Zammatteo, José Remacle, Guy Leclercq
International Journal of Biological Markers (2002) 17, 5-23

   Breast cancer remains a major cause of death in women from Western Countries. In a near future, advances in both nucleic acids technology and tumor biology should be widely exploited to improve diagnosis, prognosis, and outcome prediction of this disease. The DNA microarray, also called biochip, is a promising tool for performing massive, simultaneous, fast, and standardized analyses of multiple molecular markers in tumor samples. However, most currently available microarrays are expensive, which is mainly due to the amount (several thousands) of different DNA capture sequences that they carry. While these high-density microarrays are best suited for basic studies, their introduction into the clinical routine remains hypothetical. We describe here the principles of a low-density microarray, carrying only a few hundreds of capture sequences specific to markers whose importance in breast cancer is generally recognized, or suggested by the current medical literature. We provide a list of about 250 of these markers. We also examine some potential difficulties (homologies between marker and/or variant sequences, size of sequences, etc.) associated with the production of such a low-cost microarray.

Markers: ABCB1, ABCC1, ABCG2, AIB3, ANGPT1, AP1S2, APC, APPBP2, AR, ARHC, ATM, BACE2, BAG1, BAK1, BAX, BCAR1, BCAR3, BCAS1, BCAS2, BCL2, BCL2L1, BECN1, BIN1, BRCA1, BRCA2, BRMS1, BSG, BZRP, CALCR, CALML3, CAV1, CCND1, CD24, CD44, CD9, CDC25A, CDH1, CDH11, CDH13, CDH2, CDKN1A, CDKN1B, CDKN1C, CDKN2A, CEACAM5, CLDN1, CSE1L, CSF1, CSF1R, CSPG2, CST6, CSTA, CTGF, CTNNB1, CTSB, CTSD, CTSL, CYP19, CYP1A1, CYP1B1, CYR61, DCC, DCN, DDIT3, DFNA5, DRIM, DSP, ECGF1, EDN1, EDN3, EDNRB, EGF, EGFR, EIF4E, EMP1, EMS1, ENG, ERBB2, ERBB3, ERBB4, ESR1, ESR2, ETS1, ETV4, F2R, FABP3, FABP7, FGF2, FGF8, FGFR1, FGFR2, FHIT, FIGF, FLT1, FLT4, FN1, GATA3, GJA1, GJB1, GJB2, GRN, GSN, GSTM3, GSTP1, HGF, HIF1A, HMG1, HPSE, HSPA5, HSPB1, HSPCA, HSPCB, HXB, IBSP, ICAM1, ID1, IL11, IL1A, IL1B, IL6, IL6R, IL6ST, IL8, IMP-1, ING1, ITGA6, ITGAV, ITGB1, ITGB3, JUP, KAI1, KDR, KISS1, KLK10, KLK3, KPNA2, KRT5, KRT7, KRT8, KRT14, KRT18, KRT19, KRT20, LAMA3, LAMB3, LAMC2, LAP18, LASP1, LOX, LOXL1, LUM, MAD2L1, MAP3K8, MAWD, MCAM, MDM2, MET, MGB1, MGB2, MKI67, MLN64, MMP1, MMP11, MMP13, MMP14, MMP15, MMP2, MMP3, MMP7, MMP9, MSN, MST1R, MT1E, MTA1, MUC1, MVP, MYB, MYBL2, MYC, NCOA1, NCOA2, NCOA3, NCOR1, NCOR2, NF2, NLVCF, NME1, NME2, NR3C1, ODC1, P8, PCNA, PDZK1, PECAM1, PGR, PI3, PIP, PLAT, PLAU, PLAUR, PLD1, PLU-1, PPARBP, PTGS2, PTHLH, PXN, RAD51C, RB1, RPB1, REA, RPS6KB1, S100A2, S100A4, S100A6, S100A7, SAFB, SERPINB2, SERBINB5, SERPINE1, SFN, SLC9A3R1, SNAI1, SNCG, SOD2, SPARC, SPP1, SPRR1A, SRA1, STK15, TBX2, TEK, TERC, TERT, TFF1, TGFA, TGFB1, TGFB2, TGFB3, TGFBR2, TGFBR3, THBS1, THBS2, TIMP1, TIMP2, TJP1, TJP2, TMSB10, TNF, TOP2A, TP53, TRAF4, TSP50, TYMS, VDR, VEGF, VEGFB, VEGFC, VIM, WISP2, WISP3, WT1, ZNF217


To obtain a copy (PDF file) of this paper, please CLICK HERE or contact the Webmaster.



Main Menu



Webmaster / Webmestre: Marc Lacroix
This page hosted by/Page hébergée par
Get your own Free Home Page /Obtenez votre page personnelle gratuite

Made in BELGIUM / WALLONIA / EUREGIO MAAS-RHINE - Fait en BELGIQUE / WALLONIE / EUREGIO MEUSE-RHIN - (Molecular breast cancer - Cancer du sein, aspects moléculaires) Marc Lacroix & SciMedWeb® 2002-2009